Search results
Showing: 10 of 365
General Pharmaceutical Services – England: Notices of correction
2015/16 to 2024/25 Annual summary statisticsDate of notice: 23 October 2025An error was identified in table 20 of the supporting summary tables for this release.For financial years 2022/23, 2023/24, and 2024/25 application decisions across all…
Understanding penalty charges
In England, patients pay for their NHS prescriptions and NHS dental treatment. This is an important source of funding for the NHS.
Each year, the NHS loses significant funds due to people claiming free prescriptions or dental treatment they weren’t…
Quarterly Collections
We manage the Quarterly Collections service on behalf of the Department of Health and Social Care (DHSC).Companies are required to submit data on a quarterly basis to DHSC in accordance with the Health Service Products (Provision and Disclosure of…
New forecasted deadlines for Remediable Service Statements announced - information for employers
It was announced on Thursday 21 May 2026, in a Written Ministerial Statement to Parliament, that revised forecasted deadlines for the Public Service Pensions Remedy (also known as McCloud) have now been set.These deadlines are the latest dates by…
Personalisation of recall intervals
As highlighted in NHS England’s first stage of Dental Reform letter, data is required covering a patient’s oral health at the point of check-up. Therefore, we’ve made some changes to the clinical data set to include new items:
Highest BPE sextant…
NHS Discharge Medicines Service
The NHS Discharge Medicines Service (NHS DMS) is a new essential service for community pharmacy contractors. As an essential service, it must be provided by all community pharmacy contractors.The service has been established to:…
Introduction
The NHS Business Services Authority (NHSBSA) is a forward thinking, innovative organisation. We help the NHS to run efficiently by providing platforms, and delivering services that support the priorities of the NHS, government, and local health…
Changes to Drug Tariff determination - SSP034
This is an announcement on behalf of the Department of Health and Social Care
Pharmacy contractors should note for SSP034, where the patient has previously been supplied with a spacer, and the alternative inhaler to be supplied to the patient in…
Band 3 Inlay Claiming
The NHSBSA carried out an analysis of FP17 submissions relating to Band 3 Inlay treatment delivered in the 2017/18 financial year and identified an unusual distribution of Inlay claiming nationally.
The majority of contracts submit few or no Band 3…
Refreshed ESR exit questionnaire launching soon
NHS England and NHS Improvement, NHS Wales and NHSBSA have been working closely together to make improvements to the ESR exit questions. From October 2021 the ESR exit questionnaire will be updated with a new set of questions drawing on themes from…